Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Barnes

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
The discovery of diazepinone-based 5-HT3 receptor partial agonistsDavid D Manning, Cheng Guo, Zhenjun Zhang, et al.
Acta Biomaterialia|August 24, 2025
Structuring of gellan hydrogel enables the production of inherently antifibrotic, lubricating eye dropsSamuel R Moxon, Rachel C Vincent, A Taylor, et al.
Journal of Personalized Medicine|August 27, 2021
ILB<sup>®</sup> Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral SclerosisGiacomo Lazzarino, Renata Mangione, Antonio Belli, et al.
BMJ Open|March 24, 2023
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosisÉimear M Foley, Sian Lowri Griffiths, Alexander Murray, et al.
Biosensors & Bioelectronics|August 27, 2022
Triazole-derivatized near-infrared cyanine dyes enable local functional fluorescent imaging of ocular inflammationChloe N Thomas, Nada Alfahad, Nicholas Capewell, et al.
Nature Communications|February 6, 2024
Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic statusAidan Anderson, Nada Alfahad, Dulani Wimalachandra, et al.
NPJ Regenerative Medicine|December 28, 2018
Sustained release of decorin to the surface of the eye enables scarless corneal regenerationLisa J Hill, Richard J A Moakes, Chairut Vareechon, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2020
CSTI-300 (SMP-100); a Novel 5-HT<sub>3</sub> Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D Powell, et al.
Cell Reports|November 7, 2019
Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4<sup>+</sup> T Cell Engulfment ProcessScott P Davies, Gary M Reynolds, Alex L Wilkinson, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
The discovery of diazepinone-based 5-HT3 receptor partial agonistsDavid D Manning, Cheng Guo, Zhenjun Zhang, et al.
Acta Biomaterialia|August 24, 2025
Structuring of gellan hydrogel enables the production of inherently antifibrotic, lubricating eye dropsSamuel R Moxon, Rachel C Vincent, A Taylor, et al.
Journal of Personalized Medicine|August 27, 2021
ILB<sup>®</sup> Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral SclerosisGiacomo Lazzarino, Renata Mangione, Antonio Belli, et al.
BMJ Open|March 24, 2023
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosisÉimear M Foley, Sian Lowri Griffiths, Alexander Murray, et al.
Biosensors & Bioelectronics|August 27, 2022
Triazole-derivatized near-infrared cyanine dyes enable local functional fluorescent imaging of ocular inflammationChloe N Thomas, Nada Alfahad, Nicholas Capewell, et al.
Nature Communications|February 6, 2024
Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic statusAidan Anderson, Nada Alfahad, Dulani Wimalachandra, et al.
NPJ Regenerative Medicine|December 28, 2018
Sustained release of decorin to the surface of the eye enables scarless corneal regenerationLisa J Hill, Richard J A Moakes, Chairut Vareechon, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2020
CSTI-300 (SMP-100); a Novel 5-HT<sub>3</sub> Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D Powell, et al.
Cell Reports|November 7, 2019
Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4<sup>+</sup> T Cell Engulfment ProcessScott P Davies, Gary M Reynolds, Alex L Wilkinson, et al.
Pageof 8